Product Information

TADALAFIL 2.5 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1164 per EA under NDC 16714007402. Its NADAC has been published 299 times since Dec 2, 2020.

FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 2.5 MG TABLET

Tadalafil
$0.1164per EA

Strength

2.5 mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714007402

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA208934

FDA Approved

3/26/2019

TE Code

AB1

On Market Since

2/19/2020

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 2.5 MG TABLET has been published 299 times since Dec 2, 2020, and over the history we have for it it has declined 57.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1164 per EA
All-time high$0.2819 (Mar 10, 2021)
All-time low$0.0828 (Jul 17, 2024)
52-week high$0.1298
52-week low$0.1143
Median price$0.1603
Average price$0.1594
Largest weekly change+53.6% (Aug 21, 2024)
Weeks tracked299
Tracking sinceDec 2, 2020

Price History

1W

+1.9%

1M

+1.9%

3M

-1.0%

6M

-4.8%

1Y

-10.3%

3Y

-34.2%

5Y

-31.0%

All

-57.7%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TADALAFIL 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 2.5 MG TABLET, manufactured by NorthStar Rx LLC, is $0.1164 per EA (NDC 16714007402), effective Aug 19, 2026.

How has the price of TADALAFIL 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 2.5 MG TABLET has declined 57.7%. It has been tracked across 299 weekly CMS publications since Dec 2, 2020.

What are the highest and lowest recorded NADAC prices for TADALAFIL 2.5 MG TABLET?

Since Dec 2, 2020, the NADAC for TADALAFIL 2.5 MG TABLET has ranged from a low of $0.0828 (Jul 17, 2024) to a high of $0.2819 (Mar 10, 2021), with a median of $0.1603 per EA.

Are there cheaper alternatives to TADALAFIL 2.5 MG TABLET?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 2.5 MG TABLET, is $0.1124 per EA — about 3% below TADALAFIL 2.5 MG TABLET.

Who manufactures TADALAFIL 2.5 MG TABLET?

TADALAFIL 2.5 MG TABLET (NDC 16714007402) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.